3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Lung Neoplasms
2
Kidney Neoplasms
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Urothelial Bladder Carcinoma
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Recurrence
1
Ovarian Neoplasms
1
Metastatic Urothelial Cancer
1
Melanoma
1
Lung Diseases
1
Glioblastoma
1
Esophageal Neoplasms
1
Erythrocytosis, Familial, 4
1
Cholangiocarcinoma
1
Advanced Solid Tumors
1
Advanced Non-Small Cell Lung Cancer
1
Interventions
tislelizumab
4
pembrolizumab
4
Injections
4
toripalimab
3
sotorasib
1
serabelisib
1
olaparib
1
nedaplatin
1
mirdametinib
1
erdafitinib
1
envafolimab
1
darolutamide
1
atezolizumab
1
adagrasib
1
abiraterone
1
Taxes
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Fulvestrant
1
Drug Therapy
1
CD3 Complex
1
Bevacizumab
1
Antineoplastic Agents
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumor
×
zimberelimab
×
90 days
×
Clear all
No trials found.